Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: July 16, 2024
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: December 14, 2023
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Journal: Cancer medicine
Published: July 13, 2022
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2021
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 02, 2021
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
Journal: Journal of surgical oncology
Published: May 31, 2021
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.
Journal: Annals of surgical oncology
Published: April 30, 2021
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Journal: Cancer medicine
Published: November 03, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Journal: The oncologist
Published: June 21, 2020
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 24, 2019
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Journal: Lancet (London, England)
Published: June 14, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026